Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38253232b9c80a30df27ee79f9767c35 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
1994-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_173da9e2d77b256acec3d08842dd4c05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e478acd9a6a0aa3a1bf66176938e7e20 |
publicationDate |
1998-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-5804214-A |
titleOfInvention |
Monolithic matrix transdermal delivery system for delivering ketorolac tromethamine |
abstract |
PCT No. PCT/US94/07544 Sec. 371 Date May 20, 1996 Sec. 102(e) Date May 20, 1996 PCT Filed Jul. 6, 1994 PCT Pub. No. WO95/01767 PCT Pub. Date Jan. 19, 1995This invention provides monolithic matrix formulations for transdermal administration of ketorolac tromethamine. The device includes a copolymer of 2-ethylhexyl acrylate, 2-hydroxyethylmethacrylate, and methacrylic acid. This invention also provides transdermal devices having a monolithic matrix made using such a formulation in combination with an active ingredient and a vehicle or vehicle formulation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6262329-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6797276-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0127173-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6369182-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8911742-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112999199-A |
priorityDate |
1993-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |